621 Dupilumab in adolescents with moderate-to-severe atopic dermatitis and a history of inadequate response, or intolerance to cyclosporine: subgroup analysis from a pivotal 16-week trial

Authors
Category Primary study
JournalJournal of Investigative Dermatology
Year 2019
This article has no abstract
Epistemonikos ID: 4fc9dcfaabb6d395014b1d3df132b75380f3be30
First added on: Feb 10, 2025